Basilea Pharmaceutica AG (BPMUF)
84.00
0.00 (0.00%)
USD |
OTCM |
Nov 17, 16:00
Basilea Pharmaceutica Price : 84.00 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 84.00 | 84.00 | 84.00 | 84.00 | 0.000 |
| Nov 16, 2026 | 84.00 | 84.00 | 84.00 | 84.00 | 0.000 |
| Nov 13, 2026 | 84.00 | 84.00 | 84.00 | 84.00 | 0.000 |
| Nov 12, 2026 | 84.00 | 84.00 | 84.00 | 84.00 | 0.000 |
| Nov 11, 2026 | 84.00 | 84.00 | 84.00 | 84.00 | 10.00 |
| Nov 10, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Nov 09, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Nov 06, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Nov 05, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Nov 04, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Nov 03, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Nov 02, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 30, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 29, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 28, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 27, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 26, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 23, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 22, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 21, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 20, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 19, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 16, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 15, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
| Oct 14, 2026 | 76.25 | 76.25 | 76.25 | 76.25 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Santhera Pharmaceuticals Holding AG | 18.30 |
| BeOne Medicines Ltd. | 404.61 |
| AC Immune SA | 2.08 |
| CRISPR Therapeutics AG | 41.50 |
| Idorsia Ltd. | 4.70 |
Price Related Metrics
| PE Ratio | 17.07 |
| PS Ratio | 3.689 |
| Price to Free Cash Flow | 16.12 |
| Earnings Yield | 5.86% |
| Market Cap | 1.042B |
| Operating PE Ratio | 15.43 |
| Normalized PE Ratio | 17.07 |